Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Rhonda Germany Ballintyn currently holds 14,266 shares of INTEGRA LIFESCIENCES HOLDINGS CORP (IART), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Rhonda Germany Ballintyn has been a net buyer of IART stock. They have purchased $209.1K and sold $0 worth of shares.
Rhonda Germany Ballintyn's most recent insider trade was on Aug 1, 2023, when they sold 11,894 shares at $36.15 per share.
Rhonda Germany Ballintyn serves as Executive at INTEGRA LIFESCIENCES HOLDINGS CORP (IART). They have executed 21 insider transactions totaling $209.1K over their tenure at the company.
Rhonda Germany Ballintyn holds the position of Executive at INTEGRA LIFESCIENCES HOLDINGS CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Rhonda Germany Ballintyn has shown a buying trading pattern, with $209.1K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Rhonda Germany Ballintyn was on Aug 1, 2023, when they sold $430.0K worth of UNVR shares. This transaction involved 11,894 shares at $36.15 per share.
Rhonda Germany Ballintyn currently owns 14,266 shares of INTEGRA LIFESCIENCES HOLDINGS CORP (IART), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Rhonda Germany Ballintyn's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Rhonda Germany Ballintyn has 21 Form 4 filings on record as an insider at INTEGRA LIFESCIENCES HOLDINGS CORP.
Set alerts for Rhonda Germany Ballintyn and 40,000+ other insiders.